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1119-96 Gender Differences in the Incidence of Coronary Artery 
Disease in Patients With Stable Angina and Positive or 
Negative Stress Test in Daily Clinical Practice in the 
Year 2002: Results of the ALKK Quality Control Registry
Joerg Friedrich, Steffen Schneider, Ulrich Tebbe, Michael Weber, Jochen Senges, Uwe 
Zeymer, Herzzentrum Ludwigshafen, Ludwigshafen, Germany
Objective: To evaluate the impact of gender on prevalence of CAD (any coronary steno-
sis > 50%) in patients with stable angina and stress test performed before angiography.
Methods: In 2002 a total of 123.328 consecutive invasive procedures in 81 hospitals of
the ALKK were prospectively included into the ALKK quality control registry. 33% of
patients were female, mean age was 65 years. From these 48.617 patients had stable
angina with a positive (n=32,506; 66.8%) or negative (n=16,111; 33.2%) stress test
before angiography.
Results:
Table 1: Positive stress test 
Table 2: Negative stress test
Conclusions: In patients with stable angina the incidence of a false positive stress test is
double as high in women as in men. Stress testing has a significantly lower positive but a
higher negative predictive value for CAD in women.
1119-97 Prognostic Value of Circulating B-Type Natriuretic 
Peptide in Patients With Stable Coronary Artery Disease
Torbjorn Omland, Mark Richards, Harald Vik-Mo, Akershus University Hospital, 
Nordbyhagen, Norway, Christchurch Hospital, Christchurch, New Zealand
Background: B-type natriuretic peptide (BNP) levels are strong predictors of survival in
patients with acute coronary syndromes and in patients with congestive heart failure.
Whether plasma concentrations of B-type natriuretic peptide (BNP) are predictive of
long-term survival in patients with angiographically documented, clinically stable coro-
nary artery disease is unknown.
Methods:197 patients with stable angina pectoris and angiographic evidence of signifi-
cant coronary artery disease were included. Patients with a recent myocardial infarction,
electrocardiographic evidence of ongoing ischemia, anginal pain at rest, or symptomatic
congestive heart failure were excluded.
Results: During a median follow-up of 52 months, 9 patients died. Plasma BNP levels
were significantly higher in non-survivors than in survivors (28.0 (±19.5) vs 17.8 (±12.2)
pmol/L; p=0.036) By logistic regression a history of diabetes mellitus (p=0.003), the pres-
ence of pathological Q-waves on the electrocardiogram (p=0.024), and baseline BNP lev-
els (p=0.032) were identified as significant predictors of all-cause mortality. In a stepwise
multivariate model, diabetes mellitus (p=0.002) and BNP (p=0.015) were identified as
independent prognostic indicators.
Conclusions: In patients with clinically stable, angiographically documented coronary
artery disease, plasma BNP provides prognostic information beyond that obtained from
standard risk markers. BNP determination may have a role in risk stratification in this
large and important patient group.
1119-98 Protective Role of Low C-Reactive Protein Levels 
Against Classical Risk Factors for Coronary 
Atherosclerotic Disease
Domenico Cianflone, Cosmo Godino, Marco Magnoni, Stefano Coli, Marinica Savino, 
Claudia Monaco, Gaetano A. Lanza, Antonio Rebuzzi, Filippo Crea, Attilio Maseri, 
Università Vità Salute San Raffaele, Milano, Italy, Università Cattolica del Sacro Cuore, 
Roma, Italy
Background: Despite the presence of multiple traditional risk factors some patients do
not develop significant coronary atherosclerosis (CAD). We studied the prevalence of this
phenomenon in order to search for possible protective factors against the deleterious
effects of multiple risk factors.
Methods: Out of 1890 consecutive patients (pts) with stable angina admitted for elective
coronary angiography, between January 1998 to December 1999, we identified 84 pts
with 3 or more conventionally defined risk factors (hypercholesterolemia, diabetes, hyper-
tension, obesity, smoking, family history of CAD) and a normal coronary angiography. All
angiographies were then reviewed quantitatively (Medis QCA). 44 pts (group A) had
completely normal arteries (23 male, range 38-76 years old; risk factors: 75% family his-
tory, 23% diabetes, 68% hypercholesterolemia, 70% smoking, 75% hypertension, 23%
obesity).
As a control group we selected in our clinical database 44 pts (group B), matched for sex,
age and risk factors, with multivessel (> 70% stenosis) CAD, clinically stable for more
than 6 months. Blood levels of hs-CRP and HDL and LDL cholesterol were measured in
all pts.
Results: As expected from the inclusion criteria, no difference was observed between
group A and B in classical risk factors prevalence and blood cholesterol levels
(mean±SD; HDL 41.7±9.8 mg/dl vs 43.5±13.2 mg/dl and LDL 136.1±35.0 mg/dl vs
141.0±43.7 mg/dl respectively). Conversely there was a statistically significant difference
between the hs-CRP values between group A and B (median and 25°-75° percentile
respectively 1.97 mg/l; 0.93-4.73 mg/l vs 2.97 mg/l, 1.61-5.06 mg/l; p < 0.05).
Conclusions: Despite the presence of multiple coronary risk factors, pts with low hs-
CRP values may have angiographically normal coronary arteries, suggesting that a
chronic subclinical inflammation may be a necessary condition for the development of
angiographically detectable coronary atherosclerosis.
1119-99 Immunoglobulin A Anticardiolipin Antibodies Are 
Markers of the Extent of Daily Life Ischemia in Patients 
With Stable Angina
Ignatios Ikonomidis, John Lekakis, Felicita Andreotti, Panagiota Konstantopoulou, Sozos 
Loizou, Margarita Marinou, Petros Nihoyannopoulos, Myron Mavrikakis, University of 
Athens, Alexandra Hospital, Athens, Greece, Hammersmith Hospital, Imperial College, 
London, United Kingdom
Anticardiolipin antibodies (ACA) present procoagulant activity and cause significant
endothelial dysfunction when binding on the cell surface. We investigated whether ACA
plasma levels are related to platelet activation, thrombin generation and daily life
ischaemia in patients with stable angina (SA).
METHODS: We measured (mean±SE) IgG, IgM, IgA ACA plasma levels (mg/dl), pro-
thrombin fragments (PF1+2, nmole/l), 24h urine excretion of 11-dehydrothromboxane B2
(DHTXB2, ng/ml, creatinine) in 60 patients with SA and in 20 matched for age and ath-
erosclerotic risk factors controls. Patients had angiographically documented disease and
underwent a 48h Holter monitoring for assessment of the number and duration of
ischaemic episodes.
RESULTS: Patients had higher IgA-ACA plasma levels than controls (4.3±0.45 vs
2.2±0.17, p<0.01). Increased IgA-ACA were related to increased number and duration of
ischaemic episodes (r=0.41 and r=0.48, respectively, p<0.01). Patients with >10
ischaemic episodes (n=14) or duration of ischaemia >30min (n=18) had higher IgA ACA
than those with <10 episodes or <30 min duration (6.4±0.9 vs 3.4±0.4, p=0.007 and
5.6±0.7vs 3.2±0.5, p=0.018 respectively). ROC curve analysis showed that IgA-ACA lev-
els >3.4 mg/dl predicted a number of ischaemic episodes >10 or duration of
ischaemia>30 min with 75% and 78%sensitivity and 80% and 63% specificity (area: 0.80,
CI: 0.63-0.96, p=0.006 and area: 0.78, CI: 0.58-0.94, p=0.001 respectively). High IgA-
ACA levels were related to reduced platelet count and 11DHXTB2 concentrations (r=-
0.39 and r=-0.33, p<0.01). There was no relation of ACA to prothrombin fragments.
CONCLUSION: Increased IgA-ACA levels are associated with low platelet activity and
increased ischaemic burden in patients with stable angina. IgA-ACA are related with the
extent of daily life ischaemia likely, because they cause endothelial dysfunction after
binding on the cell surface and thus, lead to reduced nitric oxide levels and transient
reduction of coronary blood flow.
1119-100 Clinical Impact of Selective Spasm Provocation Tests: 
Comparisons Between Acetylcholine and Ergonovine in 
1,508 Consecutive Examinations
Shozo Sueda, Hiroshi Fukuda, Hiroaki Kohno, Saiseikai Saijo Hospital, Saijo, Japan
Backgrounds: There are few reports regarding the concordance of coronary arterial
response between acetylcholine (ACh) and ergonovine (ER) as a spasm provocation
test.
Objectives: We compared the coronary arterial response and clinical usefulness
between selective intracoronary injection of ACh and intracoronary administration of ER.
Methods and Results: We performed 1508 consecutive selective spasm provocation
tests, consisting of 873 acetylcholine (ACh) tests and 635 ergonovine (ER) tests from
1991 to 2002. We examined the frequency of provoked spasms of each agents retro-
spectively. ACh was injected in incremental doses of 20, 50, and 80 µg into the right cor-
onary artery and 20, 50, and 100 µg into the left coronary artery. ER was administered in
10 µg/min for 4 minutes for a maximal dose of 40 µg on the right coronary artery and 16
µg/min over 4 minutes for a total dose of 64 µg on the left coronary artery. Coronary
spasm was defined as transient > 99% luminal narrowing. Intracoronary ACh provoked
spasm in 36.0% of patients and intracoronary ER induced spasms in 29.8% of patients.
In patients with ischemic heart disease, the incidence of provoked spasm was not differ-
ent between ACh tests (50.9%) and ER tests (43.8%). In contrast, the frequency of pro-
voked spasm with ACh tests (11.0%) was significantly higher (p<0.05) than that with ER
testings (6.4%) in patients without ischemic heart disease. Moreover, ACh provoked
more spasms in patients without fixed stenosis than ER (36.2% vs. 25.5%, p<0.01), and
multiple spasms were frequently observed by performing ACh tests (40.0% vs. 27.0%,
p<0.01). Major complications, such as ventricular tachycardia, shock or cardiac tampon-
ade, were observed in 1.4% of patients with ACh tests and prolonged spasm was
observed in 0.2% of patients with ER tests. The necessity of intracoronary administration
of nitroglycerine to relieve coronary spasms during ER testings (5.04%) was frequently
observed than that in ACh tests (1.49%). However, no serious irreversible complications,
such as death or acute myocardial infarction were observed in this study. Conclusion:
We concluded that both ACh and ER tests were useful as a spasm provocation test.
Male (n=21734) Female (n=10772) p-value
No CAD 16.2 % 33.5 % <0.0001
CAD 78.2 % 54.5 % <0.0001
Other cardiac diasease 5.6 % 12.0 % <0.0001
Male (n=10602) Female (n=5509) p-value
No CAD 25.7 % 41.5 % <0.0001
CAD 63.8 % 44.2 % <0.0001
Other cardiac disease 10.5 % 14.3 % <0.0001
